Cureus · 2025
Analyzing the Distribution and Antifungal Susceptibility Profile of Candida in Various Clinical Samples: A Retrospective Study From a Tertiary Care Hospital in North India.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kumar Amit, Singh Nishtha, Das Anupam, Agarwal Jyotsana
Аннотация
Introduction Candida is a leading cause of nosocomial infections due to its invasive nature and presence in prosthetic devices. Candida albicans is the most common Candida species, but prevalence varies by location. Globally, there has been a shift toward non-albicans Candida (NAC). The study aimed to determine the distribution of Candida species across various clinical samples. Materials and methods From January to December 2024, we conducted a retrospective observational study at Dr. Ram Manohar Lohia Institute of Medical Sciences (RMLIMS) Hospital in Lucknow. We reviewed antifungal resistance and patient medical information using the hospital information system. According to a database review, 1,641 Candida isolates were identified from a year's worth of clinical samples. For routine analysis, the clinical samples were processed following standard protocols. The Vitek 2 system (BioMérieux SA, Marcy-l'Étoile, France) was used to determine the antifungal susceptibility testing patterns of the isolates, while the matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS) (BioMérieux SA, Marcy-l'Étoile, France) was employed for species-level identification. Results Urine made up 772 (47.1%) of all samples, followed by respiratory samples at 445 (27.1%) and blood at 387 (23.6%). Twelve distinct species of Candida were isolated. Compared to Candida albicans 450 (27.4%), NAC species accounted for 1191 (72.6%) of the total. Candida tropicalis was the most often isolated species of NAC. Among all Candida species, fluconazole was found to be the most resistant antifungal agent. Conclusion NAC species were responsible for a notable epidemiological shift in cases of candidiasis. Regularly identifying Candida isolates at the species level and, whenever possible, using antifungal susceptibility testing to identify emerging resistant strains is crucial for management.